ESSM Position Statement on Surgical Treatment of Peyronie's Disease

Introduction: Patients with Peyronie's disease may experience significat distress. The choice of treatment depends on a variety of factors, including the stage of the disease, the presence of pain, severity and direction of the curvature, penile length and the quality of erectile function. Aim:...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Daniar Osmonov, MD, PhD, FECSM, Ahmed Ragheb, MD, PhD, FECSM, Sam Ward, MD, FEBU, FECSM, Gideon Blecher, MD, FECSM, Marco Falcone, MD, PhD, FECSM, Armin Soave, MD, PhD, FEBU, FECSM, EAA, Roland Dahlem, MD, PhD, Koenraad van Renterghem, MD, PhD, Nim Christopher, MD, PhD, Georgios Hatzichristoudoulou, MD, PhD, FEBU, FECSM, Mirko Preto, MD, PhD, Giulio Garaffa, MD, PhD, FECSM, FRCS (Eng), Maarten Albersen, MD, PhD, FEBU, FECSM, Carlo Bettocchi, MD, PhD, FECSM, Giovanni Corona, MD, PhD, FECSM, Yacov Reisman, MD, PhD, FECSM
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2022
Materias:	Peyronie's Disease Induratio Penis Plastica Acquired Penile Deviation Penile Length Penile Graft Plication Medicine R Other systems of medicine RZ201-999
Acceso en línea:	https://doaj.org/article/bf08b81ccd7848f78d6c5c756b61eea8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:bf08b81ccd7848f78d6c5c756b61eea8
record_format	dspace
spelling	oai:doaj.org-article:bf08b81ccd7848f78d6c5c756b61eea82021-11-24T04:28:21ZESSM Position Statement on Surgical Treatment of Peyronie's Disease2050-116110.1016/j.esxm.2021.100459https://doaj.org/article/bf08b81ccd7848f78d6c5c756b61eea82022-02-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2050116121001392https://doaj.org/toc/2050-1161Introduction: Patients with Peyronie's disease may experience significat distress. The choice of treatment depends on a variety of factors, including the stage of the disease, the presence of pain, severity and direction of the curvature, penile length and the quality of erectile function. Aim: To review the evidence associated with surgical treatment of Peyronie`s Disease and provide clinical recommendations on behalf of the European Society for Sexual Medicine. 131 peer-reviewed studies and systematic reviews, which were published from 2009 to 2019 in the English language, were included. Methods: MEDLINE, Google Scholar and EMBASE were searched for randomized clinical trials, meta-analyses, open-label prospective and retrospective studies. Main Outcome Measure: The panel provided statements on clinically relevant questions including patient involvement in the decision process, indications for surgery, choice of the approach, and the management of patient expectations. A comparison of the different grafts used in patients who have undergone plaque incision/excision and grafting in order to identify an ideal graft, has been carried out. The prevalence of postoperative complications has been summarized. Levels of evidence were provided according to the Oxford 2011 criteria and Oxford Centre for Evidence-Based Medicine recommendations. Results: In order to allow shared decision making, a patient preoperative counselling regarding the pros and cons of each intervention is recommended. In particular, adverse effects of surgical treatments should be discussed to set realistic understanding and expectations of surgical outcomes and ultimately improve postoperative satisfaction rates. Surgical treatment should be only offered in the chronic phase of the condition, when the deformity and/or degree of erectile dysfunction, prevent patients from engaging in satisfying sexual interaction, or if the deformity is the cause of severe bother. Conclusions: Current European Society for Sexual Medicine recommendations cover several aspects of Peyronie's disease treatment. These recommendations aim both to ensure patients and partners have accurate and realistic expectations of their treatment options, as well as to formulate algorithms to guide clinician management pathways.Osmonov D. et al., ESSM Position Statement on Surgical Treatment of Peyronie's Disease. Sex Med 2022;10:100459.Daniar Osmonov, MD, PhD, FECSMAhmed Ragheb, MD, PhD, FECSMSam Ward, MD, FEBU, FECSMGideon Blecher, MD, FECSMMarco Falcone, MD, PhD, FECSMArmin Soave, MD, PhD, FEBU, FECSM, EAARoland Dahlem, MD, PhDKoenraad van Renterghem, MD, PhDNim Christopher, MD, PhDGeorgios Hatzichristoudoulou, MD, PhD, FEBU, FECSMMirko Preto, MD, PhDGiulio Garaffa, MD, PhD, FECSM, FRCS (Eng)Maarten Albersen, MD, PhD, FEBU, FECSMCarlo Bettocchi, MD, PhD, FECSMGiovanni Corona, MD, PhD, FECSMYacov Reisman, MD, PhD, FECSMElsevierarticlePeyronie's DiseaseInduratio Penis PlasticaAcquired Penile DeviationPenile LengthPenile GraftPlicationMedicineROther systems of medicineRZ201-999ENSexual Medicine, Vol 10, Iss 1, Pp 100459- (2022)
institution	DOAJ
collection	DOAJ
language	EN
topic	Peyronie's Disease Induratio Penis Plastica Acquired Penile Deviation Penile Length Penile Graft Plication Medicine R Other systems of medicine RZ201-999
spellingShingle	Peyronie's Disease Induratio Penis Plastica Acquired Penile Deviation Penile Length Penile Graft Plication Medicine R Other systems of medicine RZ201-999 Daniar Osmonov, MD, PhD, FECSM Ahmed Ragheb, MD, PhD, FECSM Sam Ward, MD, FEBU, FECSM Gideon Blecher, MD, FECSM Marco Falcone, MD, PhD, FECSM Armin Soave, MD, PhD, FEBU, FECSM, EAA Roland Dahlem, MD, PhD Koenraad van Renterghem, MD, PhD Nim Christopher, MD, PhD Georgios Hatzichristoudoulou, MD, PhD, FEBU, FECSM Mirko Preto, MD, PhD Giulio Garaffa, MD, PhD, FECSM, FRCS (Eng) Maarten Albersen, MD, PhD, FEBU, FECSM Carlo Bettocchi, MD, PhD, FECSM Giovanni Corona, MD, PhD, FECSM Yacov Reisman, MD, PhD, FECSM ESSM Position Statement on Surgical Treatment of Peyronie's Disease
description	Introduction: Patients with Peyronie's disease may experience significat distress. The choice of treatment depends on a variety of factors, including the stage of the disease, the presence of pain, severity and direction of the curvature, penile length and the quality of erectile function. Aim: To review the evidence associated with surgical treatment of Peyronie`s Disease and provide clinical recommendations on behalf of the European Society for Sexual Medicine. 131 peer-reviewed studies and systematic reviews, which were published from 2009 to 2019 in the English language, were included. Methods: MEDLINE, Google Scholar and EMBASE were searched for randomized clinical trials, meta-analyses, open-label prospective and retrospective studies. Main Outcome Measure: The panel provided statements on clinically relevant questions including patient involvement in the decision process, indications for surgery, choice of the approach, and the management of patient expectations. A comparison of the different grafts used in patients who have undergone plaque incision/excision and grafting in order to identify an ideal graft, has been carried out. The prevalence of postoperative complications has been summarized. Levels of evidence were provided according to the Oxford 2011 criteria and Oxford Centre for Evidence-Based Medicine recommendations. Results: In order to allow shared decision making, a patient preoperative counselling regarding the pros and cons of each intervention is recommended. In particular, adverse effects of surgical treatments should be discussed to set realistic understanding and expectations of surgical outcomes and ultimately improve postoperative satisfaction rates. Surgical treatment should be only offered in the chronic phase of the condition, when the deformity and/or degree of erectile dysfunction, prevent patients from engaging in satisfying sexual interaction, or if the deformity is the cause of severe bother. Conclusions: Current European Society for Sexual Medicine recommendations cover several aspects of Peyronie's disease treatment. These recommendations aim both to ensure patients and partners have accurate and realistic expectations of their treatment options, as well as to formulate algorithms to guide clinician management pathways.Osmonov D. et al., ESSM Position Statement on Surgical Treatment of Peyronie's Disease. Sex Med 2022;10:100459.
format	article
author	Daniar Osmonov, MD, PhD, FECSM Ahmed Ragheb, MD, PhD, FECSM Sam Ward, MD, FEBU, FECSM Gideon Blecher, MD, FECSM Marco Falcone, MD, PhD, FECSM Armin Soave, MD, PhD, FEBU, FECSM, EAA Roland Dahlem, MD, PhD Koenraad van Renterghem, MD, PhD Nim Christopher, MD, PhD Georgios Hatzichristoudoulou, MD, PhD, FEBU, FECSM Mirko Preto, MD, PhD Giulio Garaffa, MD, PhD, FECSM, FRCS (Eng) Maarten Albersen, MD, PhD, FEBU, FECSM Carlo Bettocchi, MD, PhD, FECSM Giovanni Corona, MD, PhD, FECSM Yacov Reisman, MD, PhD, FECSM
author_facet	Daniar Osmonov, MD, PhD, FECSM Ahmed Ragheb, MD, PhD, FECSM Sam Ward, MD, FEBU, FECSM Gideon Blecher, MD, FECSM Marco Falcone, MD, PhD, FECSM Armin Soave, MD, PhD, FEBU, FECSM, EAA Roland Dahlem, MD, PhD Koenraad van Renterghem, MD, PhD Nim Christopher, MD, PhD Georgios Hatzichristoudoulou, MD, PhD, FEBU, FECSM Mirko Preto, MD, PhD Giulio Garaffa, MD, PhD, FECSM, FRCS (Eng) Maarten Albersen, MD, PhD, FEBU, FECSM Carlo Bettocchi, MD, PhD, FECSM Giovanni Corona, MD, PhD, FECSM Yacov Reisman, MD, PhD, FECSM
author_sort	Daniar Osmonov, MD, PhD, FECSM
title	ESSM Position Statement on Surgical Treatment of Peyronie's Disease
title_short	ESSM Position Statement on Surgical Treatment of Peyronie's Disease
title_full	ESSM Position Statement on Surgical Treatment of Peyronie's Disease
title_fullStr	ESSM Position Statement on Surgical Treatment of Peyronie's Disease
title_full_unstemmed	ESSM Position Statement on Surgical Treatment of Peyronie's Disease
title_sort	essm position statement on surgical treatment of peyronie's disease
publisher	Elsevier
publishDate	2022
url	https://doaj.org/article/bf08b81ccd7848f78d6c5c756b61eea8
work_keys_str_mv	AT daniarosmonovmdphdfecsm essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT ahmedraghebmdphdfecsm essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT samwardmdfebufecsm essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT gideonblechermdfecsm essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT marcofalconemdphdfecsm essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT arminsoavemdphdfebufecsmeaa essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT rolanddahlemmdphd essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT koenraadvanrenterghemmdphd essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT nimchristophermdphd essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT georgioshatzichristoudouloumdphdfebufecsm essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT mirkopretomdphd essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT giuliogaraffamdphdfecsmfrcseng essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT maartenalbersenmdphdfebufecsm essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT carlobettocchimdphdfecsm essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT giovannicoronamdphdfecsm essmpositionstatementonsurgicaltreatmentofpeyroniesdisease AT yacovreismanmdphdfecsm essmpositionstatementonsurgicaltreatmentofpeyroniesdisease
_version_	1718415998877433856

ESSM Position Statement on Surgical Treatment of Peyronie's Disease

Ejemplares similares